C-MER Medical Holdings Limited (HKG:3309)
Hong Kong
· Delayed Price · Currency is HKD 1.440
+0.040 (2.86%)
Mar 10, 2026, 2:51 PM HKT
C-MER Medical Holdings Ratios and Metrics
Market cap in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 1,664 | 2,454 | 4,294 | 6,206 | 7,926 | 6,585 | Upgrade
|
| Market Cap Growth | -34.00% | -42.85% | -30.80% | -21.70% | 20.36% | 25.03% | Upgrade
|
| Enterprise Value | 1,810 | 2,506 | 4,228 | 6,137 | 7,673 | 6,197 | Upgrade
|
| Last Close Price | 1.40 | 1.99 | 3.40 | 4.85 | 6.81 | 5.66 | Upgrade
|
| PE Ratio | - | - | 69.27 | - | 362.56 | - | Upgrade
|
| Forward PE | - | 34.42 | 34.42 | 34.42 | 34.42 | 34.42 | Upgrade
|
| PS Ratio | 0.86 | 1.28 | 2.23 | 3.58 | 7.12 | 9.41 | Upgrade
|
| PB Ratio | 0.86 | 1.30 | 2.15 | 3.11 | 5.93 | 5.08 | Upgrade
|
| P/TBV Ratio | 1.58 | 2.33 | 4.12 | 5.94 | 7.03 | 5.73 | Upgrade
|
| P/FCF Ratio | 12.16 | 19.71 | 17.48 | 81.81 | 301.86 | 84.32 | Upgrade
|
| P/OCF Ratio | 6.51 | 8.67 | 11.89 | 37.64 | 54.89 | 60.09 | Upgrade
|
| EV/Sales Ratio | 0.94 | 1.31 | 2.20 | 3.54 | 6.90 | 8.86 | Upgrade
|
| EV/EBITDA Ratio | 5.56 | 12.38 | 20.72 | 66.50 | 127.82 | 152.60 | Upgrade
|
| EV/EBIT Ratio | 14.79 | 19.45 | 33.95 | 1453.13 | 929.93 | - | Upgrade
|
| EV/FCF Ratio | 13.23 | 20.13 | 17.21 | 80.90 | 292.22 | 79.35 | Upgrade
|
| Debt / Equity Ratio | 0.22 | 0.23 | 0.18 | 0.23 | 0.35 | 0.19 | Upgrade
|
| Debt / EBITDA Ratio | 1.29 | 1.28 | 1.05 | 1.98 | 3.01 | 2.20 | Upgrade
|
| Debt / FCF Ratio | 3.09 | 3.52 | 1.48 | 5.97 | 17.96 | 3.14 | Upgrade
|
| Net Debt / Equity Ratio | -0.01 | -0.02 | -0.10 | -0.12 | 0.02 | -0.24 | Upgrade
|
| Net Debt / EBITDA Ratio | -0.06 | -0.15 | -0.95 | -2.67 | 0.49 | -7.61 | Upgrade
|
| Net Debt / FCF Ratio | -0.09 | -0.24 | -0.79 | -3.24 | 1.12 | -3.96 | Upgrade
|
| Asset Turnover | 0.70 | 0.70 | 0.68 | 0.71 | 0.62 | 0.51 | Upgrade
|
| Inventory Turnover | 25.39 | 28.03 | 26.75 | 28.52 | 25.34 | 23.54 | Upgrade
|
| Quick Ratio | 1.23 | 1.32 | 1.60 | 1.45 | 1.17 | 3.75 | Upgrade
|
| Current Ratio | 1.51 | 1.56 | 1.85 | 1.63 | 1.83 | 4.01 | Upgrade
|
| Return on Equity (ROE) | -5.12% | -5.58% | 4.33% | -2.77% | 1.23% | -0.78% | Upgrade
|
| Return on Assets (ROA) | 2.81% | 2.95% | 2.75% | 0.11% | 0.29% | -0.10% | Upgrade
|
| Return on Invested Capital (ROIC) | 6.46% | 7.04% | 4.87% | 0.27% | 0.42% | 0.98% | Upgrade
|
| Return on Capital Employed (ROCE) | 5.30% | 5.60% | 5.30% | 0.20% | 0.50% | -0.10% | Upgrade
|
| Earnings Yield | -6.97% | -5.51% | 1.44% | -0.35% | 0.28% | -0.10% | Upgrade
|
| FCF Yield | 8.22% | 5.07% | 5.72% | 1.22% | 0.33% | 1.19% | Upgrade
|
| Dividend Yield | 1.48% | 1.01% | - | - | - | 0.35% | Upgrade
|
| Payout Ratio | - | - | - | - | 105.06% | - | Upgrade
|
| Buyback Yield / Dilution | 2.00% | 1.77% | -1.82% | -7.16% | -4.22% | -3.02% | Upgrade
|
| Total Shareholder Return | 3.48% | 2.77% | -1.82% | -7.16% | -4.22% | -2.67% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.